86 related articles for article (PubMed ID: 15683733)
1. Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways.
Boehrer S; Nowak D; Hochmuth S; Kim SZ; Trepohl B; Afkir A; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Cell Signal; 2005 May; 17(5):581-95. PubMed ID: 15683733
[TBL] [Abstract][Full Text] [Related]
2. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
[TBL] [Abstract][Full Text] [Related]
3. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
[TBL] [Abstract][Full Text] [Related]
4. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.
Ou D; Wang X; Metzger DL; James RF; Pozzilli P; Plesner A; Korneluk RG; Verchere CB; Tingle AJ
Hum Immunol; 2005 Mar; 66(3):274-84. PubMed ID: 15784465
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
[TBL] [Abstract][Full Text] [Related]
7. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
Kang J; Bu J; Hao Y; Chen F
Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
10. Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.
Rudner J; Jendrossek V; Lauber K; Daniel PT; Wesselborg S; Belka C
Oncogene; 2005 Jan; 24(1):130-40. PubMed ID: 15531922
[TBL] [Abstract][Full Text] [Related]
11. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
13. Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis.
Bergmann M; Kukoc-Zivojnov N; Chow KU; Trepohl B; Hoelzer D; Weidmann E; Mitrou PS; Boehrer S
Ann Hematol; 2004 Oct; 83(10):646-53. PubMed ID: 15316756
[TBL] [Abstract][Full Text] [Related]
14. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways.
Belka C; Gruber C; Jendrossek V; Wesselborg S; Budach W
Oncogene; 2003 Jan; 22(2):176-85. PubMed ID: 12527887
[TBL] [Abstract][Full Text] [Related]
15. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
17. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
18. Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis.
Boehrer S; Nowak D; Puccetti E; Ruthardt M; Sattler N; Trepohl B; Schneider B; Hoelzer D; Mitrou PS; Chow KU
Leuk Res; 2006 May; 30(5):597-605. PubMed ID: 16513168
[TBL] [Abstract][Full Text] [Related]
19. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
20. Expression of Daxx sensitizes Jurkat T-cells to the apoptosis-inducing effect of chemotherapeutic agents.
Boehrer S; Nowak D; Kukoc-Zivojnov N; Hochmuth S; Kim SZ; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Pharmacol Res; 2005 Apr; 51(4):367-74. PubMed ID: 15683751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
